CLL/SLL

Clinical trials for CLL/SLL explained in plain language.

Never miss a new study

Get alerted when new CLL/SLL trials appear

Sign up with your email to follow new studies for CLL/SLL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1 Not yet finished but already full! 1

New pill shows promise for Hard-to-Treat lymphoma patients

Disease control Not yet recruiting

This study tests a daily oral drug called lisaftoclax in 75 adults with slow-growing lymphomas (CLL, WM, or MZL) who cannot take or have stopped responding to standard treatments. The goal is to see if the drug is safe and can shrink or control the cancer. Treatment continues as …

Matched conditions: CLL/SLL

Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control

Last updated May 17, 2026 07:02 UTC

CLL/SLL

Get alerted when new CLL/SLL trials appear

New pill shows promise for Hard-to-Treat lymphoma patients